PCA.L
Palace Capital Plc [PCA.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PCA.L Stock Summary
Top 10 Correlated ETFs
PCA.L
Top 10 Correlated Stocks
PCA.L
In the News
PCA.L Financial details
Company Rating
Sell
Market Cap
101.79M
Income
-19.37M
Revenue
66.37M
Book val./share
2.65
Cash/share
0.21
Dividend
0.04
Dividend %
0.02%
Employees
16
Optionable
No
Shortable
Yes
Earnings
15 Jun 2023
P/E
-2.74
Forward P/E
-
PEG
0.15
P/S
2.88
P/B
0.76
P/C
1142.86
P/FCF
7.27
Quick Ratio
0.32
Current Ratio
1.48
Debt / Equity
0.18
LT Debt / Equity
0.07
-
-
EPS (TTM)
-0.44
EPS next Y
-
EPS next Q
-
EPS this Y
-250.94%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
11.95%
Revenue Q/Q
-35.02%
EPS Q/Q
-99.21%
-
-
-
-
SMA20
4%
SMA50
10.9%
SMA100
2.63%
Inst Own
-
Inst Trans
-
ROA
-18%
ROE
-23%
ROC
0.05%
Gross Margin
48%
Oper. Margin
31%
Profit Margin
-108%
Payout
-18%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
200.0-265.0
52W High
-9.43%
52W Low
+20%
RSI
63
Rel Volume
0.22
Avg Volume
50.24K
Volume
11.17K
Perf Week
3.9%
Perf Month
6.67%
Perf Quarter
6.67%
Perf Half Y
5.26%
-
-
-
-
Beta
0.753965
-
-
Volatility
3.99%, 4.95%
Prev Close
0%
Price
240
Change
1.27%
PCA.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.41 | 0.46 | 0.38 | 1.06 | 0.74 | |
| Net income per share | 0.11 | -0.12 | -0.12 | 0.53 | -0.8 | |
| Operating cash flow per share | 0.15 | 0.22 | 0.14 | 0.71 | 0.32 | |
| Free cash flow per share | 0.15 | 0.21 | -0.32 | 0.56 | 0.29 | |
| Cash per share | 0.5 | 0.32 | 0.2 | 0.61 | 0.12 | |
| Book value per share | 3.93 | 3.62 | 3.43 | 3.83 | 2.89 | |
| Tangible book value per share | 3.93 | 3.62 | 3.43 | 3.83 | 2.89 | |
| Share holders equity per share | 3.93 | 3.62 | 3.43 | 3.83 | 2.89 | |
| Interest debt per share | 2.67 | 2.71 | 2.87 | 2.27 | 1.54 | |
| Market cap | 130.81M | 81.86M | 108.7M | 126.85M | 96.18M | |
| Enterprise value | 227.52M | 188.42M | 228.53M | 201.02M | 155.55M | |
| P/E ratio | 25.3 | -15.05 | -19.65 | 5.17 | -2.69 | |
| Price to sales ratio | 6.98 | 3.87 | 6.28 | 2.59 | 2.92 | |
| POCF ratio | 19.09 | 8.26 | 16.63 | 3.88 | 6.65 | |
| PFCF ratio | 19.11 | 8.29 | -7.4 | 4.85 | 7.36 | |
| P/B Ratio | 0.73 | 0.49 | 0.69 | 0.72 | 0.75 | |
| PTB ratio | 0.73 | 0.49 | 0.69 | 0.72 | 0.75 | |
| EV to sales | 12.13 | 8.91 | 13.2 | 4.1 | 4.72 | |
| Enterprise value over EBITDA | -37.59 | -12.14 | -67.18 | 7.34 | -4.83 | |
| EV to operating cash flow | 33.2 | 19.01 | 34.95 | 6.15 | 10.76 | |
| EV to free cash flow | 33.23 | 19.08 | -15.57 | 7.69 | 11.9 | |
| Earnings yield | 0.04 | -0.07 | -0.05 | 0.19 | -0.37 | |
| Free cash flow yield | 0.05 | 0.12 | -0.14 | 0.21 | 0.14 | |
| Debt to equity | 0.66 | 0.73 | 0.82 | 0.58 | 0.51 | |
| Debt to assets | 0.38 | 0.4 | 0.43 | 0.35 | 0.32 | |
| Net debt to EBITDA | -15.98 | -6.87 | -35.22 | 2.71 | -1.84 | |
| Current ratio | 7.18 | 3.68 | 1.77 | 1.34 | 1.48 | |
| Interest coverage | 3.32 | 3.57 | 3.5 | 10.02 | 2.76 | |
| Income quality | 1.33 | -1.82 | -1.18 | 1.33 | -0.4 | |
| Dividend Yield | 0.07 | 0.11 | 0.03 | 0.04 | 0.07 | |
| Payout ratio | 1.69 | -1.61 | -0.62 | 0.22 | -0.18 | |
| Sales general and administrative to revenue | 0.05 | 0.19 | 0.06 | 0.02 | 0.04 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | -3.25 | -0.2 | -0.1 | |
| Capex to revenue | 0 | 0 | -1.23 | -0.13 | -0.04 | |
| Capex to depreciation | -0.23 | -0.2 | -109.37 | -33.37 | -12.31 | |
| Stock based compensation to revenue | 0.02 | 0.01 | 0.02 | 0 | 0.01 | |
| Graham number | 3.16 | 3.1 | 3.04 | 6.76 | 7.22 | |
| ROIC | 0.03 | 0.07 | 0.04 | 0.1 | 0.05 | |
| Return on tangible assets | 0.02 | -0.02 | -0.02 | 0.09 | -0.18 | |
| Graham Net | -2.26 | -2.27 | -2.36 | -1.53 | -1.35 | |
| Working capital | 19.7M | 10.86M | 26.99M | 14.13M | 8.1M | |
| Tangible asset value | 180.32M | 166.35M | 157.83M | 177.2M | 128.48M | |
| Net current asset value | -113.11M | -122.19M | -81.51M | -55.58M | -48.18M | |
| Invested capital | 0.66 | 0.73 | 0.82 | 0.58 | 0.51 | |
| Average receivables | 2.94M | 4.15M | 5.48M | 4.1M | 2.9M | |
| Average payables | 1.11M | 2.07M | 2.03M | 873.5K | 556K | |
| Average inventory | 7.18M | 20.96M | 35.14M | 31.5M | 15.67M | |
| Days sales outstanding | 52.87 | 96.23 | 113.38 | 20.99 | 33.07 | |
| Days payables outstanding | 190.97 | 413.11 | 278.13 | 7.25 | 10.81 | |
| Days of inventory on hand | 2.23K | 3.91K | 10.39K | 243.51 | 235.32 | |
| Receivables turnover | 6.9 | 3.79 | 3.22 | 17.39 | 11.04 | |
| Payables turnover | 1.91 | 0.88 | 1.31 | 50.34 | 33.75 | |
| Inventory turnover | 0.16 | 0.09 | 0.04 | 1.5 | 1.55 | |
| ROE | 0.03 | -0.03 | -0.04 | 0.14 | -0.28 | |
| Capex per share | 0 | 0 | -0.46 | -0.14 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.6 | 0.46 | 0.32 | 0.43 | 0.29 | |
| Net income per share | 0.17 | 0.36 | -0.27 | -0.53 | 0 | |
| Operating cash flow per share | 0.39 | 0.32 | 0.08 | 0.25 | 0.07 | |
| Free cash flow per share | 0.39 | 0.32 | 0.07 | 0.22 | 0.07 | |
| Cash per share | 0.23 | 0.61 | 0.29 | 0.13 | 0.21 | |
| Book value per share | 3.54 | 3.83 | 3.46 | 2.94 | 2.65 | |
| Tangible book value per share | 3.54 | 3.83 | 3.46 | 2.94 | 2.65 | |
| Share holders equity per share | 3.54 | 3.83 | 3.46 | 2.94 | 2.65 | |
| Interest debt per share | 2.37 | 2.24 | 2.02 | 1.54 | 0.52 | |
| Market cap | 113.35M | 126.89M | 103.58M | 94.44M | 95.46M | |
| Enterprise value | 210.82M | 201.06M | 179.73M | 153.81M | 106.65M | |
| P/E ratio | 3.52 | 1.92 | -2.1 | -1.01 | -137.95 | |
| Price to sales ratio | 4.08 | 5.96 | 7.22 | 5.07 | 7.88 | |
| POCF ratio | 6.36 | 8.5 | 30.64 | 8.53 | 35.3 | |
| PFCF ratio | 6.36 | 8.51 | 30.7 | 9.73 | 35.3 | |
| P/B Ratio | 0.69 | 0.72 | 0.67 | 0.74 | 0.87 | |
| PTB ratio | 0.69 | 0.72 | 0.67 | 0.74 | 0.87 | |
| EV to sales | 7.59 | 9.44 | 12.53 | 8.25 | 8.81 | |
| Enterprise value over EBITDA | 25.82 | 29.84 | 43.89 | 24.47 | 27.72 | |
| EV to operating cash flow | 11.83 | 13.47 | 53.17 | 13.89 | 39.44 | |
| EV to free cash flow | 11.83 | 13.49 | 53.27 | 15.86 | 39.44 | |
| Earnings yield | 0.07 | 0.13 | -0.12 | -0.25 | 0 | |
| Free cash flow yield | 0.16 | 0.12 | 0.03 | 0.1 | 0.03 | |
| Debt to equity | 0.66 | 0.58 | 0.57 | 0.51 | 0.18 | |
| Debt to assets | 0.38 | 0.35 | 0.35 | 0.32 | 0.15 | |
| Net debt to EBITDA | 11.94 | 11.01 | 18.6 | 9.45 | 2.91 | |
| Current ratio | 1.3 | 1.34 | 4.2 | 1.48 | 1.35 | |
| Interest coverage | 4.99 | 4.21 | 2.35 | 2.77 | 2.41 | |
| Income quality | 2.21 | 0.9 | -0.27 | -0.47 | -15.63 | |
| Dividend Yield | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | |
| Payout ratio | 0.31 | 0.18 | -0.26 | -0.14 | -18.66 | |
| Sales general and administrative to revenue | 0.08 | 0.11 | 0.25 | 0.13 | 0.15 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | -0.12 | 0 | |
| Capex to revenue | 0 | 0 | 0 | -0.07 | 0 | |
| Capex to depreciation | -0.01 | -0.21 | -0.18 | -17.6 | 0 | |
| Stock based compensation to revenue | 0.01 | 0 | 0.01 | 0 | 0.01 | |
| Graham number | 3.72 | 5.54 | 4.62 | 5.94 | 0.5 | |
| ROIC | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | |
| Return on tangible assets | 0.03 | 0.06 | -0.05 | -0.12 | 0 | |
| Graham Net | -1.92 | -1.53 | -1.61 | -1.37 | -0.26 | |
| Working capital | 12M | 14.13M | 29.21M | 8.1M | 6.72M | |
| Tangible asset value | 163.59M | 177.2M | 155.74M | 128.48M | 109.96M | |
| Net current asset value | -66.13M | -55.58M | -58.23M | -48.18M | -1.42M | |
| Invested capital | 0.66 | 0.58 | 0.57 | 0.51 | 0.18 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 22 | 11.93 | 20.79 | 14.43 | 29.29 | |
| Days payables outstanding | 2.83 | 4.18 | 6.04 | 4.44 | 1.07 | |
| Days of inventory on hand | 139.29 | 140.45 | 219.64 | 96.68 | 117.8 | |
| Receivables turnover | 4.09 | 7.54 | 4.33 | 6.24 | 3.07 | |
| Payables turnover | 31.78 | 21.52 | 14.89 | 20.26 | 84.27 | |
| Inventory turnover | 0.65 | 0.64 | 0.41 | 0.93 | 0.76 | |
| ROE | 0.05 | 0.09 | -0.08 | -0.18 | 0 | |
| Capex per share | 0 | 0 | 0 | -0.03 | 0 |
PCA.L Frequently Asked Questions
What is Palace Capital Plc stock symbol ?
Palace Capital Plc is a GB stock and trading under the symbol PCA.L
What is Palace Capital Plc stock quote today ?
Palace Capital Plc stock price is $240 today.
Is Palace Capital Plc stock public?
Yes, Palace Capital Plc is a publicly traded company.
Company Profile
- Volume Average 50.24K
- Market Capitalization 101.79M
- Employee 16
- CEO Dr. Steven J. Owen FCA, LLB, MCT
- Headquarters London,GB
- IPO Date 2013-10-21
-
Website
https://www.palacecapitalplc.com 
Palace Capital plc is a real estate investment firm specializing in investment in entities operating in the property sector. It seeks to invest in United Kingdom. Palace Capital plc is based in London, the United Kingdom.
